Core Viewpoint - The company is experiencing positive momentum, focusing on crew and ship safety, as well as maintaining dividends, while the reduction of the grey/black fleet enhances its market position [1] Financial Performance - The dividend for Q3 2025 is set at $0.13 per share, marking the 113th consecutive quarterly cash dividend, payable on December 22, 2025, to shareholders on record as of December 8, 2025 [2] - The average time charter equivalent (TCE) for the fleet in Q3 2025 was $27,490 per day per ship, with operating costs at $9,000 per day per ship [2] - The adjusted EBITDA for Q3 2025 was $21.4 million, while a net book loss of -$2.8 million was recorded [2] - The company's cash position exceeds $70 million as of the report date [2] Market and Operational Insights - Strong demand for oil persists, with rates holding steady during a slow Q3 compared to Q2, and the fourth quarter is starting positively, allowing for cash accumulation [2] - A preliminary agreement has been made with a South Korean shipyard to construct two new Suezmax tankers for delivery in the second half of 2028, with a firm contract expected to be signed in early 2026 [2] - The fleet currently consists of 20 well-maintained Suezmax tankers [2] - The high quality of the vessels is demonstrated through favorable vetting performance by major oil companies [2] - Emissions have been reduced through careful voyage planning and speed adjustments of the ships [2]

Core Viewpoint - TextMagic AS has decided to terminate the operations of its Romanian subsidiary, TM Marketing Ops Srl, to enhance marketing efficiency and reduce costs [1] Group 1: Company Operations - The Romanian subsidiary, TM Marketing Ops Srl, has served as the group's marketing unit until now [1] - Future marketing activities will be centralized at the Estonian headquarters [1] Group 2: Strategic Objectives - The decision aims to lower administrative and operational costs associated with maintaining a separate entity [1] - The move is intended to improve overall marketing efficiency and performance [1]

Core Insights - Havila Kystruten AS published its Q3 2025 financial report on November 27, 2025, indicating the company's ongoing financial performance and strategic direction [1] - The earnings call was conducted by CEO Bent Martini and CFO Aleksander Røynesdal on November 28, 2025, providing insights into the results and future outlook [1] Financial Performance - The Q3 2025 financial report details the company's performance metrics, which are expected to be discussed in the attached presentation [2] - A recording of the earnings call will be made available on the company's website for further analysis and review [1]

Core Points - Sidetrade, a leader in AI-powered Order-to-Cash applications, has announced its financial calendar for 2026 [1][2] - The company analyzes over $7.7 trillion in B2B payment transactions daily, predicting payment behavior for over 41 million companies globally [2] Financial Calendar Summary - Annual Revenue for 2025 will be reported on January 20, 2026, after market close [1] - Annual Results for 2025 will be released on March 31, 2026, after market close [1] - First Quarter Revenue for 2026 is scheduled for April 14, 2026, after market close [1] - Annual Shareholder General Meeting for 2026 will take place on June 18, 2025, at 11:00 am (CEST) [1] - First Half Year Revenue for 2026 will be announced on July 21, 2026, after market close [1] - First Half Year Results for 2026 will be reported on September 22, 2026, after market close [2] - Third Quarter Revenue for 2026 is set for October 20, 2026, after market close [2] - Annual Revenue for 2026 will be disclosed on January 26, 2027, after market close [2] Company Overview - Sidetrade provides an AI-powered Order-to-Cash platform aimed at enhancing cash flow generation and security for companies [2] - The company employs over 450 staff across multiple countries, supporting large enterprises in over 85 countries [2] - Notable clients include AGFA, BMW Financial Services, KPMG, and Siemens [2]

Core Insights - The table presents bids, sales, stop-rates, pro-rata, and prices for specific ISINs, indicating active market participation and pricing dynamics [1] Group 1: Bids and Sales - The total bid amount is 4,960 million kr, with sales amounting to 3,940 million kr, reflecting a strong interest in the securities [1] - Individual bids include 1,200 million kr for ISIN 98 20169 DKT 03/03/26 I and 3,760 million kr for ISIN 98 20243 DKT 02/06/26 II, showing varied investor interest across different securities [1] Group 2: Stop-rates and Prices - The stop-rate for the securities is approximately 1.60% for ISIN 98 20169 DKT 03/03/26 I and 1.61% for ISIN 98 20243 DKT 02/06/26 II, indicating competitive pricing in the market [1] - The prices for the securities are 99.5972 for ISIN 98 20169 DKT 03/03/26 I and 99.1926 for ISIN 98 20243 DKT 02/06/26 II, suggesting a slight discount from par value [1] Group 3: Settlement Information - The sale is scheduled to settle on December 2, 2025, providing a timeline for investors regarding the transaction [1]

Core Viewpoint - The "AI Plus" initiative in Zhejiang Province, particularly in Qiantang District, is significantly advancing the biomedical engineering sector, with a focus on integrating artificial intelligence into drug development processes [1][3][10]. Industry Overview - Hangzhou Biopharma Town in Qiantang District is a central hub for the biomedical and medical device industry, housing over 1,800 biomedical enterprises and currently having 90 innovative drugs in clinical trials [3][12]. - The district has attracted major pharmaceutical companies, including 7 of the world's top 10, and has a biomedical output value accounting for approximately 50% of Hangzhou's total [12]. AI Integration in Drug Development - AI technology is revolutionizing drug development by significantly reducing the time and cost associated with bringing new drugs to market, with MindRank reporting a reduction of 1.5 to 3 years and over 50% in early R&D costs [4][6]. - The use of AI allows for faster and more accurate screening of molecules, enabling the discovery of original molecules and new treatment ideas for previously intractable diseases [6][7]. Infrastructure and Support - Qiantang District has established a robust industrial foundation with 15 large model projects and over 18 AI research platforms, fostering a closed-loop biomedical industry chain that integrates AI into every stage of drug R&D [13][10]. - High-level scientific and technological innovation platforms, such as Zhejiang University's Innovation Institute for Artificial Intelligence in Medicine, are providing full-cycle AI innovation services to enterprises [14][15]. Future Prospects - Qiantang District aims to enhance its industrial policies and ecological systems to transform Hangzhou Biopharma Town into a national industrial landmark, anticipating a significant breakthrough in biomedical technologies [17].

Under henvisning til Nasdaq Copenhagens regler for udstedere af investeringsbeviser skal ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg hermed på vegne af de berørte afdelinger i Værdipapirfonden Sparinvest offentliggøre, at indberetning af indre værdier til Nasdaq Copenhagen er udeblevet grundet tekniske udfordringer. Handel med de berørte afdelinger er derfor midlertidigt suspenderet.Der er tale om følgende afdelinger: Fund NameISINOrder Book CodeINDEX Globale Aktier KLDK0060747822SPVIBGKLINDEX Glob ...

Nykredit Portefølje Administration A/S har anmodet Nasdaq Copenhagen om suspension af enkelte afdelinger, som administreres af Nykredit Portefølje Administration A/S. Det skyldes, at det grundet tekniske udfordringer ikke er muligt at stille korrekt NAV. Suspensionen vil blive ophævet, når det igen er muligt at stille korrekte priser. Følgende afdelinger er omfattet af suspensionen: ISINFund NameOrder Book CodeDK0061671013Ansvarlig Defensiv KL NBIADDK0061671286Ansvarlig Moderat KL NBIAMDK0061671369Ansvarlig ...

Group 1: Company Overview - LVMH Moët Hennessy Louis Vuitton operates in various sectors including Wines and Spirits, Fashion and Leather Goods, Perfumes and Cosmetics, Watches and Jewelry, and Selective Retailing [2] - The Wines and Spirits division features brands such as Moët & Chandon, Hennessy, and Veuve Clicquot, while the Fashion and Leather Goods division includes Louis Vuitton and Christian Dior [2] - LVMH's Perfumes and Cosmetics sector includes notable brands like Fenty Beauty and Guerlain, and its Watches and Jewelry division comprises Bulgari and Tiffany & Co [2] Group 2: Financial Information - An interim dividend of €5.50 per share is scheduled for payment on December 4, 2025, with the ex-dividend date set for December 2, 2025 [1]

Core Points - The company has requested the suspension of all departments due to technical challenges [1] Group 1 - The suspension request indicates significant operational issues within the company [1]